chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Went to get out of bed and immediately fell down as if my legs weren't there. No dizziness, just no feeling.  This happened one more time about 5 minutes later when trying to get up from the toilet.  Since then, fell one more time on 10/2, but I walk slow, holding onto whatever is near and have to focus on my walking.  Tingling and numbness in fingers, hands and legs, and mostly cannot feel right side of body. 11/9/2009 records from Neuro MD  2/2009 and ED records for 10/8-10/9/2009. Patient with c/o's weakness, numbness/tingling lower extremities, tingling in fingertips and multiple falls. PE noted loss of pinprick and decreased vibration. PT eval, patient dc'd home with cane/walker. Dx tests neg. DC DX Lower extremity weakness. ICD-9 349.9 11/09/09 ICD9 codes and Discharge summary for DOS 10/08/09-10/09/09.  Final DX for 10/08-10/09: Lower extremity weakness.  C/O numbness, tingling, mutiple falls.  Paresthesias medial hands and fingers, face , lips, tingling numbness. Has had mild memory loss/forgetfullness. H/O previous ED visits for tremulousness/ severe HA. Increased fatigue. Decreased trigeminal neuralgia sx.. Embelishments on sensory exams. CT and MRI neg. Out patient PT. D/c to home with cane and walker.   1/28/09: Neuro consult visit. C.o shooting pain while getting teeth cleaned/root canal. Severe burning of jaw. Procedure stopped. Pain constant. Trigeminal neuralgia flare.  ICD9 Codes: 349.9
Continuous severe muscle pain of the entire left arm that radiates to the left armpit and partially the chest that lasts more than 43hrs so far. Chills lasted about 4hrs with high fever that were reduced by administer of ibuprofen. Night sweat. General weakness.
2/4/05 Left deltoid red, swollen and sore, c/o body aches.
34 yo mother, delivered infant in February 2022 at 36wk, 5days gestation. BW 3570gm. Infant with CARDIOMYOPATHY
Swelling of lymph nodes in armpit on left side, Intense pain within the armpit, headache, dizziness, lightheaded, nausea, fatigue, body aches, sensitive skin all symptoms showed within 12 hours of the shot being administered.  Emergency Room: treated with IV fluids, zofran, and IV Tylenol
Within first 15 minutes patient experienced hives and rash on right side of neck and tightness in chest. Severe itching and burning. Was seen in ER was given diphenhydramine, hydroxyzine inj, solu-medrol, and famotadine. Was prescribed hydroxyzine, prednisone, and famotadine outpatient. Hives and rash continued and was given solu-medrol on 10/11/2016. Patient is still experiences rash and hives and continues to be treated with hydroxyzine and a titration of prednisone.
This case was reported by a healthcare professional and described the occurrence of a large, red ring around the injection site in a 43-year-old female subject who was vaccinated with Flulaval for prophylaxis. There were no concurrent medication. On 24 October 2007 at 14:05 the subject received unspecified dose of Flulaval at 0.5 ml in the left arm. on 24 October 2007, 1 hour after vaccination with Flulaval, the subject experienced a red ring at the injection site that was reportedly the size of a silver dollar. The following morning, on 25 October 2007, the subject developed a rash on the chest area. The subject experienced both a local and a systemic reaction to the vaccine. The subject was treated with Benadryl and Tylenol. At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with Flulaval.
No additional adverse event reported; HCP reports a 15 year old patient, weighting 126 pounds was accidently administered an adult dose of VAQTA instead of a pediatric dose on Jun 27, 2022.; This spontaneous report was received from a medical assistant concerning a 15-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.    On 27-JUN-2022, the patient was accidently vaccinated with an adult dose of Hepatitis A Vaccine, inactivated (VAQTA) (dosage regimen, lot#, expiration date, route of administration and anatomical location were not provided) as prophylaxis, instead of a pediatric dose (product administered to patient of inappropriate age).  No further information or adverse event were reported (no adverse event).
Approximately 11 days after receiving the booster dosenn by of the Moderna vaccine, I began having  widespread erythematous maculopapular rash which appears with minimal trauma, pressure, showering, etc.
15 MINUTES AFTER INJECTION 90 YEAR OLD FEMALE WITH PREVIOUS HISTORY OF DEMENTIA/PSYCOSIS SYMTOMS SAID SHE COULDN'T WALK TO CAR AND STARTED TRYING TO SPIT. WHEN PHARMACIST WENT TO PATIENT SHE TOLD HER TO LET HER ALONE-SHE WANTED TO GO HOME AND WAS KICKING AND TRYING TO HIT PHARMACIST.  911 WAS CALLED-AMBULANCE SHOWED UP AND PT CAREGIVER DECLINED CARE-JUST WANTED TO MAKE SURE PATIENT WAS NOT HAVING ALLERGIC REACTION TO VACCINEE AND PHARMACIST AND EMT SAID NO.  IF HE HAD ANY CONCERNS HE CAN CALL BACK TO 911.
really sick; Initial information received on 13-Sep-2023 regarding an unsolicited valid social media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who was really sick after receiving influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer via unknown route in unknown administration site for prophylactic vaccination (strength, dose, formulation, batch number and expiry date: unknown). Information on the batch number was requested  On an unknown date the patient was really sick (illness) (unknown latency).  It is unknown if there were lab data/results available  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (illness).  At time of reporting, the outcome was Unknown for the event (illness).
Patient was vaccinated with 12+ Pfizer bivalent instead of Pfizer bivalent, which is the correct one for this 10 year old.
Initial misuse report received from a healthcare professional on 12 November 2013. On unspecified date an 11 year patient received DAPTACEL vaccine instead of ADACEL vaccine. Wrong vaccine was administered. No adverse event was reported. List of documents held by sender: none.
At 1230 pm (14 minute after receiving the vaccine), the client c/o dizziness.  Clt was not pale or diaphoretic.   We instructed her to lay down with her feet elevated.  Vitals taken: 98% spo2 and HR 51.  At 1235 patient sat up.  Spo2 99% HR 52. Clt  stated she "felt better."  At 1245 BP checked 130/80.   Patient said she felt better and left observation area with a steady gait.
1SEP98 mom noticed redness & swelling @ site of DTAP inj;2SEP98 area worse-more red & swollen-area around shoulder swollen;
Patient became light headed and dizzy after Covid-19 vaccination. Blood pressure (134/74), O2 Sat (99%), and pulse (92) all WNL. Water given and cold compress applied to forehead. Pt stated that she still wasn't feeling well. Pt's aunt came over to talk to her. Pt looked up at Aunt and said "seizure". Pt began to convulse. Ambulance called. Pt placed on floor per HD staff. APN examined pt. EMT's arrived and questioned pt and had her sit upright in floor. Pt answered questions and then began to convulse again. EMT's transported pt to hospital after convulsing stopped.
redness, swelling and pain to the eye at 9:30 p.m. on day of vaccination received vaccine around 3:40 p.m. took contacts out around 9 p.m. and noticed swelling to eye 30 minutes later stated, "I'm not sure if I scratched my eyelid getting the contacts out or if it's a reaction to the vaccine." took Benadryl and used ice pack which "seemed to provide relief" - advised to contact primary care doctor and register with V-safe
Pt developed left arm pain and swelling, erythema extending from deltoid to elbow. Treated with Benadryl.
pt recvd vax & exp elevated LDH, elevated SGOT, a 20-pound weight loss, anorexia, & was tired;
Severe fever and chills for 2 days Pain at injection site Severe muscle and joint pain for 2 days Weakness/fatigue for a few weeks Severe headaches for 2 days, then more vague headaches for several days
Headache prior to shot but increased in intensity around 7 hours after injection, continued throughout night, disrupting sleep, severe the following morning, then began to recede in intensity about 24 hours after injection
Tuesday night - Fever, body aches, Diarrhea and it lasted through Wednesday - Friday. I didn't work those three days. I went to the doctor on Friday. By Friday afternoon I was doing better. I was feeling better on Saturday.
Severe stomach cramps and diarrhea last 4 hours with associated nausea.
Currently taking medrol dose pack, azithromycin, magnesium, Flonase with minimal relief. Exam of right ear (experiencing symptoms) shows no visual signs, normal in appearance. Dr stated diagnosis is irreversible and there?s no specific medication for treatment.
shoulder pain; This is a spontaneous report from a Pfizer-sponsored program COVAX US SUPPORT. A contactable male consumer (patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.   Patient received second dose of Pfizer COVID vaccine this morning. He has shoulder pain and he had shoulder pain and issues with his shoulder prior to receiving the vaccine. Patient would like to know if he can use Aspercreme with Lidocaine on his shoulder. He had shoulder pain before taking the 2nd dose this morning, asked if he can rub a cream on his shoulder. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Very sore arm for two days, slight headache for 1 day,  Upset stomach that comes and goes after waking in the morning and after meals. persistent and still ongoing after4 days
Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/2/2022 Discharge Date: Jun 8, 2022  PRESENTING PROBLEM: Non-small cell carcinoma of lung, stage 4, unspecified laterality (HCC)    HOSPITAL COURSE: Patient is a 85 y.o. with a history of stage IV squamous cell carcinoma of the lung, a gastric cancer status post resection, Sjogren's on Plaquenil, breast cancer, hypertension, hyperlipidemia, PVD presented to the hospital with abdominal pain.  She was septic on admission with a leukocytosis of 33 and a lactic acidosis of 3.2 which resolved with fluid resuscitation.  COVID testing was positive.  CT imaging was consistent with post obstruction pneumonia secondary to lung mass.  Pulmonology was consulted and recommended broad-spectrum antibiotics, she completed 5 days of Zosyn.  GI was consulted due to melena and recommended proton pump inhibitor therapy and to defer endoscopy.  On admission, she was adamant about full code status.  Palliative Care and heme Onc had an extensive goals of care discussion regarding the prognosis of her cancer.  They told her that with or without palliative chemotherapy her likely prognosis is within the span of weeks to months.  She and her family chose to pursue do not resuscitate while admitted and hospice on discharge.   On 06/08/2022 she was discharged in stable condition to home with hospice.   Medications were reviewed and all questions were answered.
Headache & Myalgia Narrative: required intervention with ibuprofen 400mg
Patient called to state she had a clot on 12/13/21 following her vaccine the previous week (vaccine date was actually 11/15/21 which she confirmed) pt had no issues with first 2 doses but has had a history of clot and cardiovacular disease
balance is off; temperature; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BALANCE DISORDER (balance is off) and BODY TEMPERATURE DECREASED (temperature) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010MZ0A) for COVID-19 vaccination.     Concomitant products included Blood pressure medication for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (balance is off) and BODY TEMPERATURE DECREASED (temperature). At the time of the report, BALANCE DISORDER (balance is off) and BODY TEMPERATURE DECREASED (temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Within 4 mins throat was feeling like it was swelling. Then it resolved. 24 hours later started with fever of 103. Then 3 days later started with facial rash similar to shingles, arms and legs blistered. Day 4 rash on your abdomen under breasts. Patient reports still having rash. Doctor originally dx as poison ivy. Reseen patient and changed dx to covid-19 reaction to vaccine. Patient was placed on steriods and is on second round of steriods.
On the day of my shot, I had a severe headache.  The following day, I had some body aches but the headache and body aches were gone by the end of the second day.  Starting 3/14, I developed an itchy, mildly painful rash on forearms, hands, and lower leg - ongoing.
This spontaneous report was received from an other healthcare professional refers to a patient of unknown age and gender. There was no information about patient's pertinent medical history, concomitant medications, drug reactions or allergies reported. On 23-OCT-2015, the patient was vaccinated with improperly stored dose of oral, ROTATEQ (lot# reported as L022446, expiration date 14-FEB-2017, dose was not reported; orally). No adverse effects were reported. Additional information has been requested.
Headache, Myalgia,  Insomnia incapacitating insomnia, headache fatigue, myalgias. Treated with fluids and bedrest.
Erythema and pain at site of injection, entire upper arm, still evident after 3 days. Warm to the touch. Headache on day two.
A spontaneous report was sent by non health professional concerning a female patient of unknown age who received Modern's COVID-19 vaccine (mRNA-1273) and experienced tenderness at the injection site, itchy rash, redness, feeling hot, muscle tightness and diagnosed cellulitis and She also stated that her outsides edges were a brighter red than in the center.  The patient's medical history was unknown. The Concomitant medication was unknown.  03 Mar 2021, prior to the onset of the events, the patient received the first dose of mRNA-1273 (Lot number: 014M20A) via unknown route in right arm for prophylaxis of COVID-19 infection.  On 3 Mar 2021 she felt only tenderness at the injection site,   On 13 Mar 2021, 10 days later she developed a rash the size of her fist, it went from her shoulder to about a quarter away from her elbow, it itched like crazy. She did not have temperature but her arm was hot to touch, muscle was tight and was diagnosed as cellulitis.   The patient still feel a difference in texture of the skin. She also stated that her outsides edges were brighter red than in the center.  Treatment was unknown. No laboratory details are provided.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of vaccination site pain was resolved on same day, itchy rash was resolved till 19 mar 2021, redness, muscle tightness and feeling hot was resolved on 17 Mar 2021 and unknown for cellulitis.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
07/14/16-rash and pain at injection site-worsened. 07/15/16-Rash increased to bilateral arms, neck, face, head, ears, thighs and petechia. By midday 07/15/16--Also with numbness of lips and throat swelling without difficulty swallowing/breathing; mild cough and hoarse voice. 07/15/16-Approx. 1 PM- seen at ER-given prednisone, PEPCID and VISTARIL. Improved quickly.
allergic reaction; vertigo; memory loss / He couldn't remember anything.; He's very tired and sleeps all day; He's very tired and sleeps all day; he lost a lot of weight of about 75 pounds; This is a spontaneous report from a contactable consumer reporting on behalf of her husband. A 64-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Apr2021, at the age of 64 years, lot EN6201, as the first single dose, for COVID-19 immunisation. Prior vaccinations (within 4 weeks): none. Medical history included back pain (taking medicine for his back), deep vein thrombosis before vaccination and was on blood thinner, bleeding disorder (he was on blood thinner), diverticulitis before vaccination, allergy to penicillin and iodine. Both his parents had heart issues. Concomitant medication included tramadol orally, ongoing from an unknown date, 50 mg tablet 1x/day, for back pain and rivaroxaban (XARELTO) as blood thinner for DVT. The patient experienced an allergic reaction of vertigo on 16Apr2021. He was prescribed by the primary doctor with dramamine to calm it down and it worked for a week. From an unspecified date in 2021 he had also memory loss, he lost a lot of weight of about 75 pounds after 16Apr2021. He was 288 now 212. Since he lost the weight, back pain had stabilized. He couldn't remember anything. He was very tired and slept all day. He was not him. On 07May2021 he received the second dose. Allergic reaction of vertigo had not yet resolved. The other events outcome was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101022334 Same Reporter/Patient/Drug, Different AE/Vaccine Dose
Administered 0.5 mg Flu vaccine left deltoid at 10:20AM. AT 10:35AM pt alerted staff of flushing, "swallowing strange" and "tongue curling". At 10:40AM Benadryl 25mg given. At 12:30PM pt reports resolution of symptoms, swallowing and tongue sensation. SL. residual groggy 2 hours Benadryl.
Client was discovered to be under age post vaccination due to his large size. This incident occurred in a drive thru. Mass vaccination Clinic. No obvious distress noted post vaccination. But person was only 13 years old.
Back pain, discomfort, and possibly sciatica pain; Back pain, discomfort, and possibly sciatica pain; Back pain, discomfort, and possibly sciatica pain; This is a spontaneous report from a contactable consumer or other non hcp.  A 65-years-old male patient received BNT162B2,(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as Ist dose, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient experienced back pain, discomfort, and possibly sciatica pain, back pain, discomfort, and possibly sciatica pain on an unspecified date. Therapeutic measures were taken as a result of back pain, discomfort, and possibly sciatica pain, back pain, discomfort, and possibly sciatica pain. Outcome of the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Chills; Fever of 102.2; headache; This is a spontaneous report from a contactable Nurse, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the right arm on 17Mar2021 at 09:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included pacemaker, allergic asthma, history of Hodgkin, hypothyroid and high cholesterol. Allergies to medications, food, or other products was reported to penicillin, codeine, morphine, latex sensitive. Concomitant medications included montelukast (SINGULAIR), rosuvastatin (CRESTOR), levothyroxine (MANUFACTURER UNKNOWN), triamcinolone acetonide (NASACORT) and Vitamin (Unspecified), all for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021 at 10:00, the patient experienced chills, fever of 102.2 and headache. The reported events resulted in Doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the reported events. The clinical outcome of the events chills, fever and headache was recovering.   No follow-up attempts are needed. No further information is expected
Patient had possible rabies exposure 5/30. Bat was caught and sent for testing. Upon positive rabies test, patient returned to ED and started PEP. Patient received rabies vaccine and immune globulin 6/2. Patient received another dose of rabies vaccine 6/5, 6/9, and 6/12. The fourth dose was given 13 days post exposure, but only 10 days post the initial vaccine which was 4 days early according to the guidelines.
Muscle pain all over my body and strongest in my back and the injection site; Severe headaches; Muscle pain all over my body and strongest in my back and the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headaches), MYALGIA (Muscle pain all over my body and strongest in my back and the injection site) and INJECTION SITE PAIN (Muscle pain all over my body and strongest in my back and the injection site) in a 38-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 3031279) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    The patient's past medical history included COVID-19.   On 11-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient received dose of INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) (unknown route) 1 dosage form. On 12-Oct-2023, the patient experienced HEADACHE (Severe headaches) and MYALGIA (Muscle pain all over my body and strongest in my back and the injection site). On an unknown date, the patient experienced INJECTION SITE PAIN (Muscle pain all over my body and strongest in my back and the injection site). At the time of the report, HEADACHE (Severe headaches), MYALGIA (Muscle pain all over my body and strongest in my back and the injection site) and INJECTION SITE PAIN (Muscle pain all over my body and strongest in my back and the injection site) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) was unknown.       Treatment medications was not reported.  After the shot, the patient had severe headache behind the eye balls that continued throughout the day and into the evening. Additionally the patient had muscle pain all over the body and had back pain and the injection site pain. The patient received flu shot at the same time.  question 9 was left unanswered since the applicable option was not available in the decision tree.
Information has been received from a nurse concerning an 8 year old white male who on 09MAR1998, was vaccinated with a dose of varicella virus vaccine live. The nurse reported that on 30MAY2003, the patient developed a generalized rash characterized by less than 50 lesions. The patient was noted to be afebrile with no cough. It was unknown if medical attention was sought. On 05JUN2003, the patient recovered from generalized rash. Additional information has been requested.